Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?

Neuropsychopharmacology, Published online: 27 January 2020; doi:10.1038/s41386-020-0619-xRepurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?

Source: Neuropsychopharmacology - January 26, 2020 Category: Neurology Authors: Morgan H. James Jennifer E. Fragale R. Nisha Aurora Nina A. Cooperman Daniel D. Langleben Gary Aston-Jones Source Type: research